CYTOKINETICS INC — Director's Dealing 2025

Feb 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2025-02-04

Reporting Person: Malik Fady Ibraham (EVP Research & Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-04	Common Stock	M	2000	$10.60	Acquired	118071	Direct
2025-02-04	Common Stock	S	2000	$48.06	Disposed	116071	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-04	Non-Qualified Stock Option (Right to Buy)	$10.60	M	2000	Disposed	2027-02-28	Common Stock (2000)	Direct